Summit Global Investments’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,439
Closed -$1.01M 508
2024
Q4
$1.01M Sell
2,439
-13
-0.5% -$5.7K 0.06% 213
2024
Q3
$1.24M Hold
2,452
0.08% 209
2024
Q2
$1.2M Hold
2,452
0.08% 206
2024
Q1
$1.32M Sell
2,452
-5,709
-70% -$3.12M 0.1% 166
2023
Q4
$4.53M Buy
8,161
+12
+0.1% +$5.63K 0.3% 72
2023
Q3
$3.56M Sell
8,149
-6,483
-44% -$3.23M 0.24% 89
2023
Q2
$7.35M Buy
+14,632
New +$7.01M 0.49% 53
2022
Q1
Sell
-37,753
Closed -$24.9M 513
2021
Q4
$24.9M Buy
37,753
+3,115
+9% +$1.96M 1.6% 12
2021
Q3
$21.5M Sell
34,638
-312
-0.9% -$210K 1.61% 12
2021
Q2
$22.1M Sell
34,950
-16,183
-32% -$8.94M 1.32% 10
2021
Q1
$25M Sell
51,133
-12,562
-20% -$6.29M 1.6% 8
2020
Q4
$31.8M Sell
63,695
-2,490
-4% -$1.11M 3.18% 5
2020
Q3
$26M Buy
66,185
+1,285
+2% +$475K 2.69% 8
2020
Q2
$21.4M Sell
64,900
-5,418
-8% -$1.57M 2.47% 10
2020
Q1
$17M Buy
70,318
+46,763
+199% +$12.2M 2.48% 8
2019
Q4
$6.15M Buy
23,555
+208
+0.9% +$54.8K 0.67% 51
2019
Q3
$6.35M Buy
23,347
+782
+3% +$218K 0.74% 48
2019
Q2
$6.21M Sell
22,565
-246
-1% -$60.6K 0.78% 44
2019
Q1
$5.1M Sell
22,811
-311
-1% -$64.2K 0.65% 51
2018
Q4
$4.3M Buy
23,122
+286
+1% +$58.6K 0.67% 49
2018
Q3
$5.7M Sell
22,836
-30
-0.1% -$7.28K 0.77% 46
2018
Q2
$4.98M Buy
+22,866
New +$4.71M 0.75% 48

Other funds holding IDXX

Summit Global Investments's IDXX Position: Q1 2025 in Review

Summit Global Investments sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 2,439 shares — an estimated $1.01M sold.

Summit Global Investments first reported a position in IDXX in Q2 2018 and held it in 22 quarters. The position peaked at $31.8M in Q4 2020. 1,143 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

  • Summit Global Investments reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
  • Summit Global Investments sold 2,439 Idexx Laboratories shares in Q1 2025, an estimated $1.01M.
  • Summit Global Investments first reported a position in Idexx Laboratories in Q2 2018 and held it in 22 quarters.
  • Summit Global Investments's Idexx Laboratories position peaked at $31.8M in Q4 2020.
  • 1,143 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Summit Global Investments's 13F filing for Q1 2025, filed 7 Apr 2025.